Pfizer scrapped its own obesity drug candidate, Danuglipron, in early 2025, citing risks of liver enzyme elevations. ・The ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Ibex’s high-performance AI platform—already deployed across more than 50 health systems worldwide and used in collaboration ...

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Explore how Insilico collaborates with Servier to advance AI-driven drug discovery in oncology for unmet medical needs.

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a ...

This episode of the Pharmaron DMPK Insights Podcast Series sees Simon Taylor (Vice President of Drug Discovery at Pharmaron) and Dr. Emile Chen (former Director of Modeling and Translational Biology ...

Oct 28 (Reuters) - Laboratory services provider Labcorp (LH.N), opens new tab forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to ...

Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...